Almanack Investment Partners’s Repligen RGEN Stock Holding History

Almanack Investment Partners’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,600	Closed	-$299K	–	448
2020 Q3	$299K	Buy	+1,600	New	+$229K	0.04%	297

Other funds holding RGEN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Almanack Investment Partners's RGEN Position: Q4 2020 in Review

Almanack Investment Partners sold out of Repligen (RGEN) in Q4 2020, closing a stake of 1,600 shares — an estimated $299K sold.

Almanack Investment Partners first reported a position in RGEN in Q3 2020 and held it in 1 quarter. The position peaked at $299K in Q3 2020. 449 funds tracked by Wall St. Rank hold RGEN as of Q4 2020.

Almanack Investment Partners reported no remaining Repligen position as of Q4 2020 after selling out during the quarter.
Almanack Investment Partners sold 1,600 Repligen shares in Q4 2020, an estimated $299K.
Almanack Investment Partners first reported a position in Repligen in Q3 2020 and held it in 1 quarter.
Almanack Investment Partners's Repligen position peaked at $299K in Q3 2020.
449 funds tracked by Wall St. Rank held Repligen as of Q4 2020.

Based on Almanack Investment Partners's 13F filing for Q4 2020, filed 3 Feb 2021.